Recombinant Human TFPI Protein, C-His Tag_天津卡梅德科技发展有限公司

KRP159

组织因子途径抑制剂, Tissue factor pathway inhibitor , TFPI, Extrinsic pathway inhibitor, EPI, Lipoprotein-associated coagulation inhibitor, LACI, LACI, TFPI1,

DATASHEET MSDS

产品介绍

Catalog Number	KRP159
Alias	组织因子途径抑制剂, Tissue factor pathway inhibitor , TFPI, Extrinsic pathway inhibitor, EPI, Lipoprotein-associated coagulation inhibitor, LACI, LACI, TFPI1,
Size	20ug, 50ug, 100ug, 200ug, 1mg
Product Description	Human TFPI(Asp29-Lys282)
Molecular Name	TFPI
Product Introduction	组织因子途径抑制剂通过抑制外源性途径，调节凝血和免疫反应。。
Molecular Weight	37-50 kDa
Expression System	HEK293F Cells
Species	Human
Concentration	联系销售经理获得最新批次的浓度
Purity	≥95%
SDS-PAGE
Purification	Affinity Purification
Uniprot ID	P10646
Storage Condition	Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
Formulation	Supplied in PBS
Shipping Condition	This product is shipped on ice packs or dry ice.
Background	Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma. {ECO:0000269\|PubMed:20676107}.
Endotoxin	< 0.1 EU per ug
Biological Activity	Measured by its ability to inhibit trypsin cleavage of a fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2. The IC50 value is <0.41 nM.
Product Declaration	该产品仅供科研使用，不可直接用于人体或注射。